ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
6,032.38
0.56%
US Tech 100
20,389.60
0.88%
다우존스 지수
44,910.65
0.42%
Bitcoin
96,456.38
0.02%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. MedTech Acquisition Corporation (MTAC)

  7. MedTech Acquisition Corporation (MTAC) 뉴스

MTAC

MedTech Acquisition (MTAC)

MedTech Acquisition Corporation
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:MTAC
일자시간출처헤드라인심볼기업
2023/08/0306:00Business WireMedTech Acquisition Corporation Adjourns Special Meeting of StockholdersNASDAQ:MTACMedTech Acquisition Corporation
2023/06/2805:14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MTACMedTech Acquisition Corporation
2023/06/2306:07Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:MTACMedTech Acquisition Corporation
2023/06/1606:14Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:MTACMedTech Acquisition Corporation
2023/06/1605:11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MTACMedTech Acquisition Corporation
2023/06/1220:06Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:MTACMedTech Acquisition Corporation
2023/06/1220:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MTACMedTech Acquisition Corporation
2023/06/1220:00Business WireTriSalus Life Sciences Presents Additional Data for SD-101 Delivered by the Proprietary PEDD™ Method with the TriNav™ Device for Uveal Melanoma Liver Metastases at the ASCO 2023 Annual MeetingNASDAQ:MTACMedTech Acquisition Corporation
2023/06/0820:01Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:MTACMedTech Acquisition Corporation
2023/06/0820:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MTACMedTech Acquisition Corporation
2023/05/2505:29Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:MTACMedTech Acquisition Corporation
2023/05/1520:01Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:MTACMedTech Acquisition Corporation
2023/05/1520:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MTACMedTech Acquisition Corporation
2023/04/2206:12Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:MTACMedTech Acquisition Corporation
2023/04/2020:07Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:MTACMedTech Acquisition Corporation
2023/04/2020:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MTACMedTech Acquisition Corporation
2023/04/2020:00Business WireTriSalus Life Sciences Presents New Data at AACR for SD-101 Delivered by the Proprietary PEDD™ Method in Stage IV Uveal Melanoma Patients With Liver MetastasesNASDAQ:MTACMedTech Acquisition Corporation
2023/04/0605:32Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:MTACMedTech Acquisition Corporation
2023/04/0605:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MTACMedTech Acquisition Corporation
2023/03/2305:17Edgar (US Regulatory)Annual Report (10-k)NASDAQ:MTACMedTech Acquisition Corporation
2023/03/0906:34Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:MTACMedTech Acquisition Corporation
2023/03/0906:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MTACMedTech Acquisition Corporation
2023/02/2121:08Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:MTACMedTech Acquisition Corporation
2023/02/2121:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MTACMedTech Acquisition Corporation
2023/02/2121:00Business WireTriSalus Life Sciences Appoints James Alecxih to Lead Device Technology BusinessNASDAQ:MTACMedTech Acquisition Corporation
2023/02/1621:08Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:MTACMedTech Acquisition Corporation
2023/02/1621:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MTACMedTech Acquisition Corporation
2023/02/1007:29Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:MTACMedTech Acquisition Corporation
2023/02/0923:24Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:MTACMedTech Acquisition Corporation
2023/02/0904:11Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:MTACMedTech Acquisition Corporation
 검색 관련기사 보기:NASDAQ:MTAC

최근 히스토리

PM
XAUUSD
Gold vs US Dollar
NASDAQ
NVDA
NVIDIA
COIN
DOGEUSD
Dogecoin
AMEX
XLF
Financial Select Sector
COIN
SOLUSD
Solana
NASDAQ
TSLA
Tesla
CCOM
US100
US Tech 100
USI
USTECH100
US Tech 100
COIN
ETHUSD
Ethereum
USOTC
BASFY
BASF (QX)
NYSE
NKE
Nike
NYSE
KO
Coca Cola
FX
USDGBP
US Dollar vs Sterling
NASDAQ
GOOGL
Alphabet
NYSE
JPM
JP Morgan Chase
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유